Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Stopped-flow Light Scattering Analysis of Red Blood Cell Glycerol Permeability

Gena, Patrizia ; Portincasa, Piero ; Matera, Sabino LU ; Sonntag, Yonathan LU ; Rützler, Michael LU and Calamita, Giuseppe (2020) In Bio-protocol 10(16).
Abstract

Stopped-Flow Light Scattering (SFLS) is a method devised to analyze the kinetics of fast chemical reactions that result in a significant change of the average molecular weight and/or in the shape of the reaction substrates. Several modifications of the original stopped-flow system have been made leading to a significant extension of its technical applications. One of these modifications allows the biophysical characterization of the water and solute permeability of biological and artificial membranes. Here, we describe a protocol of SFLS to measure the glycerol permeability of isolated human red blood cells (RBCs) and evaluate the pharmacokinetics properties (selectivity and potency) of isoform-specific inhibitors of AQP3, AQP7 and... (More)

Stopped-Flow Light Scattering (SFLS) is a method devised to analyze the kinetics of fast chemical reactions that result in a significant change of the average molecular weight and/or in the shape of the reaction substrates. Several modifications of the original stopped-flow system have been made leading to a significant extension of its technical applications. One of these modifications allows the biophysical characterization of the water and solute permeability of biological and artificial membranes. Here, we describe a protocol of SFLS to measure the glycerol permeability of isolated human red blood cells (RBCs) and evaluate the pharmacokinetics properties (selectivity and potency) of isoform-specific inhibitors of AQP3, AQP7 and AQP9, three mammalian aquaglyceroporins allowing transport of glycerol across membranes. Suspensions of RBCs (1% hematocrit) are exposed to an inwardly directed gradient of 100 mM glycerol in a SFLS apparatus at 20 °C and the resulting changes in scattered light intensity are recorded at a monochromatic wavelength of 530 nm for 120 s. The SFLS apparatus is set up to have a dead time of 1.6-ms and 99% mixing efficiency in less than 1 ms. Data are fitted to a single exponential function and the related time constant (τ, seconds) of the cell-swelling phase of light scattering corresponding to the osmotic movement of water that accompanies the entry of glycerol into erythrocytes is measured. The coefficient of glycerol permeability (Pgly, cm/s) of RBCs is calculated with the following equation: Pgly = 1/[(S/V)τ] where τ (s) is the fitted exponential time constant and S/V is the surface-to-volume ratio (cm-1) of the analyzed RBC specimen. Pharmacokinetics of the isoform-specific inhibitors of AQP3, AQP7 and AQP9 are assessed by evaluating the extent of RBC Pgly values resulting after the exposure to serial concentrations of the blockers.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Aquaglyceroporins, Aquaporin inhibitors, Erythrocytes, Glycerol membrane permeability, Stopped-flow light scattering
in
Bio-protocol
volume
10
issue
16
article number
e3723
publisher
Bio-protocol LLC
external identifiers
  • scopus:85150612710
ISSN
2331-8325
DOI
10.21769/BioProtoc.3723
language
English
LU publication?
yes
id
b22f0256-499d-45e8-a5ff-18dfc0cb5890
date added to LUP
2023-05-30 10:20:22
date last changed
2023-05-30 10:20:22
@article{b22f0256-499d-45e8-a5ff-18dfc0cb5890,
  abstract     = {{<p>Stopped-Flow Light Scattering (SFLS) is a method devised to analyze the kinetics of fast chemical reactions that result in a significant change of the average molecular weight and/or in the shape of the reaction substrates. Several modifications of the original stopped-flow system have been made leading to a significant extension of its technical applications. One of these modifications allows the biophysical characterization of the water and solute permeability of biological and artificial membranes. Here, we describe a protocol of SFLS to measure the glycerol permeability of isolated human red blood cells (RBCs) and evaluate the pharmacokinetics properties (selectivity and potency) of isoform-specific inhibitors of AQP3, AQP7 and AQP9, three mammalian aquaglyceroporins allowing transport of glycerol across membranes. Suspensions of RBCs (1% hematocrit) are exposed to an inwardly directed gradient of 100 mM glycerol in a SFLS apparatus at 20 °C and the resulting changes in scattered light intensity are recorded at a monochromatic wavelength of 530 nm for 120 s. The SFLS apparatus is set up to have a dead time of 1.6-ms and 99% mixing efficiency in less than 1 ms. Data are fitted to a single exponential function and the related time constant (τ, seconds) of the cell-swelling phase of light scattering corresponding to the osmotic movement of water that accompanies the entry of glycerol into erythrocytes is measured. The coefficient of glycerol permeability (Pgly, cm/s) of RBCs is calculated with the following equation: Pgly = 1/[(S/V)τ] where τ (s) is the fitted exponential time constant and S/V is the surface-to-volume ratio (cm<sup>-1</sup>) of the analyzed RBC specimen. Pharmacokinetics of the isoform-specific inhibitors of AQP3, AQP7 and AQP9 are assessed by evaluating the extent of RBC Pgly values resulting after the exposure to serial concentrations of the blockers.</p>}},
  author       = {{Gena, Patrizia and Portincasa, Piero and Matera, Sabino and Sonntag, Yonathan and Rützler, Michael and Calamita, Giuseppe}},
  issn         = {{2331-8325}},
  keywords     = {{Aquaglyceroporins; Aquaporin inhibitors; Erythrocytes; Glycerol membrane permeability; Stopped-flow light scattering}},
  language     = {{eng}},
  number       = {{16}},
  publisher    = {{Bio-protocol LLC}},
  series       = {{Bio-protocol}},
  title        = {{Stopped-flow Light Scattering Analysis of Red Blood Cell Glycerol Permeability}},
  url          = {{http://dx.doi.org/10.21769/BioProtoc.3723}},
  doi          = {{10.21769/BioProtoc.3723}},
  volume       = {{10}},
  year         = {{2020}},
}